Clinical trials
Recruiting Recurrence trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
206 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 15 |
| 2023 | 25 |
| 2024 | 50 |
| 2025 | 58 |
| 2026 | 37 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 206 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 9 |
| The First Affiliated Hospital of Soochow University | 9 |
| Beijing Biotech | 8 |
| Fudan University | 7 |
| Institute of Hematology & Blood Diseases Hospital, China | 7 |
| Chinese PLA General Hospital | 5 |
| AstraZeneca | 4 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 4 |
| The First Affiliated Hospital of Xiamen University | 4 |
| Tongji Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 206 |
| Multiple Myeloma | 27 |
| Neoplasm Metastasis | 16 |
| Leukemia, Myeloid, Acute | 15 |
| Lymphoma, B-Cell | 11 |
| Nasopharyngeal Carcinoma | 11 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Neoplasms | 8 |
| Carcinoma, Hepatocellular | 7 |
| Hematologic Neoplasms | 7 |
Trials
Showing 1 to 25 of 206. Each trial links to its page on Pharma Observatory.
106 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.